尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Fisher Andrew. Officer active across 1 company, notably Verona Pharma plc. In total, 8 filings have been recorded. History available since 30 October 2024. The latest transaction was filed on 1 August 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Fisher Andrew is a declarant linked to Verona Pharma plc, where he is General Counsel. The record shows 8 filings in total, and among the sampled recent filings the period runs from 2024-11-01 to 2025-10-08, with transaction nature indicated as option exercise; the aggregated buy and sell amounts for that sample are both EUR 0.